Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / V••••••• C••••••• T•••••• L••

WindRose H••••• Investors Announces Recapitalization of V••••••• C••••••• T•••••

Majority recapitalizationclosedannounced Aug 6, 2026closed Aug 6, 2026Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
healthcare / clinic
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • W••••••• H••••• I••••••••• L•• ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of V••••••• C••••••• T•••••• L•• ("VCT" or the "Company"), the global leader in solutions addressing patient safety, compliance, and data integrity fro
Advisory side
  • C••••• F••••••••• • C••Financial adviserconfirmed
    C••••• F••••••••• • C•• acted as exclusive financial advisor to VCT.
  • M•••••••• W••• • S•••••• L••Legal adviserconfirmed
    M•••••••• W••• • S•••••• L•• served as legal advisor to VCT.
  • L••••• • W•••••• L••Legal adviserconfirmed
    L••••• • W•••••• L•• served as legal advisor to WindRose.
Side not stated
  • W••••••• H••••• I••••••••• L•• ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of V••••••• C••••••• T•••••• L•• ("VCT" or the "Company"), the global leader in solutions addressing patient safety, compliance, and data integrity fro
Evidence
W••••••• H••••• I••••••••• L•• ("WindRose"), the New York-based healthcare private equity firm, announced that it has completed the recapitalization of V••••••• C••••••• T•••••• L•• ("VCT" or the "Company"), the global leader in solutions addressing patient safety, compliance, and data integrity from patient enrollment through study completion.
WindRose H••••• Investors Announces Recapitalization of V••••••• C••••••• T••••• | Private Equity Intelligence | DFX